Bangladesh signs MoU with Indian Company for collecting 3 crores Coronavirus vaccine

▴ Bangladesh signs MoU with Indian Company for collecting 3 crores Coronavirus vaccine
An MoU was signed on 5th Nov between the government of Bangladesh, Beximco Pharmaceutical Ltd and the Serum Institute of India for priority delivery of 3 crores COVID-19 vaccine doses.

The process of development of the vaccine is in the final stages at the University of Oxford and AstraZeneca.

Health Minister of Bangladesh Zahid Maleque and High Commissioner of India to Bangladesh Vikram Doraiswami were present on the occasion along with other senior officials of the Health Ministry of Bangladesh and the two companies.

Calling it a ‘landmark agreement’, Health Minister Zahid Maleque expressed the hope that the people of Bangladesh will get relief from this. He said that initially 1.5 crore people will be vaccinated as each person will require two doses of the vaccine.

High Commissioner Vikram Doraiswami said that the vaccine from India was chosen not only because it was the best price but also because it is most suitable for the conditions for the distribution of the vaccine in Bangladesh.

He said that the vaccine is also one of the most promising candidates which are being brought up to the international regulators. The High Commissioner said that it is the culmination of the agenda that Prime Minister Narendra Modi put forward in March this year when he told SAARC leaders that this battle should be fought together and won together.

Meanwhile, new air service between India and Bangladesh under the air-bubble arrangement started yesterday. Welcoming the start of the new service, Bangladesh State Minister for Civil Aviation Md. Mahbub Ali said that the air-bubble arrangement between the two countries has helped people who need to travel for medical, business, and other purposes. He pointed out that Bangladesh and India enjoyed excellent relations and Prime Minister Sheikh Hasina is working to further strengthen people to people ties between the two countries.

Tags : #Bangladesh #India #AstraZeneca #UniversityofOxford #PMNarendraModi #PMSeikhHasina #COVIDvaccine #LatestPharmaNews6thNov

About the Author


Team Medicircle

Related Stories

Loading Please wait...

-Advertisements-



Trending Now

The Value of Risk Communication in Public HealthOctober 08, 2026
What Makes a Reliable Health Screening Programme?October 08, 2026
How Language Access Can Improve Patient Communication in Indian HealthcareOctober 07, 2026
Why Health Literacy Matters in Preventive HealthcareOctober 07, 2026
Improving Follow-Up After Diagnostic Testing: Where Systems Commonly Break DownOctober 07, 2026
Improving Follow-Up After Diagnostic Testing: Where Systems Commonly Break DownOctober 07, 2026
How Community Health Workers Support Preventive Care DeliveryOctober 07, 2026
AI in India's Emergency Departments: Reducing Diagnostic DelaysOctober 06, 2026
AI and Patient Consent in India: Who Is Responsible?October 06, 2026
Wearable Technology in Pregnancy: Benefits and LimitsOctober 06, 2026
Remote Monitoring for High-Risk Pregnancies in IndiaOctober 06, 2026
Fortis Escorts Faridabad Launches ‘Sehat Express’ Mobile Bus for Accessible Doorstep Cancer Screening in association with Faridabad Industries Association Charitable Society and Rotary Club FaridabadOctober 05, 2026
Advanced Thrombectomy Saves 60-Year-Old Woman After Severe Heart Attack at KIMS SaveeraOctober 05, 2026
Constipation, Bloating and Long Sitting Hours: Doctors at RG Hospitals Delhi Warn Urban Professionals Not to Ignore Gut ProblemsOctober 05, 2026
Fermenta – Centre of Excellence for Food Fortification Inaugurated at NIFTEM-T, ThanjavurOctober 05, 2026
Alzheimer’s Dementia: Recognising the Signs, Diagnosing Earlier and Changing the Future of Brain HealthOctober 05, 2026
Man Matters Hairfall Case Study 2026: 7 Lakh+ Consultations Reveal How Hair Loss Changes With AgeOctober 05, 2026
Medication Reconciliation: A System-Level Step for Safer Transitions of CareOctober 05, 2026
The Role of Clinical Pharmacists in Safer Medication UseOctober 05, 2026
Nanavati Max Hospital Hosts Max Cancer Congress 2026, Bringing Together Oncology Experts to Explore the Future of Cancer Care October 01, 2026